We report here the complete heavy and light chain variable region sequences of seven heterohybridomas derived from CD5+ chronic lymphocytic leukemia (CLL) B lymphocytes and displaying natural autoantibody activity. The three hybrids displaying a polyreactive pattern of binding used VH4 family members, ie, the VH4-18 gene in germinal configuration in two cases and a VH4 gene with 90% homology with VH4-21 for the third one. A hybrid expressing antiSm activity used a VH3 family member with 95.26% homology with the 30P1 gene. The three hybrids exclusively displaying rheumatoid factor activity expressed VH1 family genes: 51 P1 gene for two (in germinal configuration in one, and with 93.2% homology in the other), whereas the third one used the V1-3b gene (98.8% homology). Definitive homology with known germline D segments was found for four of the seven hybrids (DN2 in 3 and DLR4 in 1 ) ATURAL autoantibodies (NAAB) constitute an im-N portant part of the normal B-cell repertoire.'" They frequently display a widespread pattern of binding'-3 and are the products of clones expressing germline Ig variable region genes."' CD5+ B cells have been postulated to constitute a separate B-cell lineage, predominating early in ontogeny and reputed to be committed mainly to secreting these NAAB.9 Because B-cell chronic lymphocytic leukemia (B-CLL) is a malignancy arising from clonal expansion of morphologically small mature CD5+ B lymphocytes, we examined this question in a previous report by deriving hetero-hybridomas from malignant CD5+ CLL B lymphocytes." In agreement with other reports,",'2 we found a high incidence of NAAB activity among these hybrids.
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Ig heavy chain variable regions are formed through the association of discontinuous genetic elements (variable heavy [VH] , diversity [D] , and joining [J] ) that rearrange during B-cell ontogeny. In humans, VH genes have been divided into seven families on the basis of greater than 80% shared nucleotide homology, whereas there exist at least 30 different D segments and 6 functional JH segments. VHl and VH3 families are highly polymorphic and appear to contain greater than 70% of all VH genes, although they may include high numbers of pseudogenes. The VH2 family contains about 5 different genes, VH4 at least 14, VH5 at least 2, VH6 a single gene" and the recently described VH7 5 to 8 different genes.I4 Evidence exists indicating random usage of these genes in adult lymphoid tissues.13 However, developmentally regulated expression of VH genes appears to exist, because there is overexpression of the J H proximal genes during early ontogeny in
In humans, only a limited number of VH genes are expressed during fetal life and there exists developmentally regulated expression of JH ~egments.'~ The human K locus'8 contains approximately 85 VK gene segments, divided into four different families (VKI to VKIV), and the X locus appears to contain at least 50 VX gene segments belonging to seven different groups. " Early reports suggested that V gene usage in CLL might be nonrandom, because expression of the VH4, VH5, and and JH use appeared to be random. The three hybrids displaying polyreactive activity expressed VKI, VXIII, and VXll genes, all in germinal configuration. Among the three hybrids with rheumatoid factor activity, two used the same V~l l gene with, respectively, 98% and 96% homology with a gene previously described; the third used a VXI gene in germinal configuration. Finally, the clone with anti-Sm activity used a VXlll gene having 97% homology with a germinal gene. Overall, these results attempt to establish the relationship between frequent self-reactivity observed in CD5+ B-CLL and V gene usage. For VH genes, they confirm overexpression of the 51 P I gene in B-CLL and suggest nonstochastic use of two VH4 genes (4-21 and 4-1 8). For VL genes, available information is too scarce to lead to firm conclusions. 0 1993 by The American Society of Hematology.
VH6 minifamilies was found to vary from 40% to 80% among CLLS.~O-~~ This idea was reinforced by the finding that certain genes, such as VH5-251," VH1-51Pl,24 and V K I I I -H U~K V~~~,~~,~~ were overexpressed with high frequency. Nonstochastic expression ofthese V genes might be explained by the frequent autoantigen-binding activity of CLL B cells.'' Continuous challenge by self-antigens may contribute to clonal selection and expansion of these cells." However, the relationship between antibody activity and gene usage has not been defined in the majority of CLLs studied. We report here the complete heavy and light chain nucleotide sequence of 7 hybrids derived from CD5+ CLL B cells that also display autoantibody activity.
MATERIALS AND METHODS
Heterohybridomas studied were derived by fusing peripheral blood lymphocytes (PBLs) from CD5+ B-CLL patients with the nonsecreting myeloma X63.653, as previously described." The main characteristics of hybrids are summarized in Table 1 . It is shown that hybrids Mal, Mar, and Col displayed polyreactive binding activity, whereas hybrids Fon, Aig, and Por displayed rheumatoid activity; hybrid Huc showed anti-Sm activity. In all cases, hybrids were found to express the same heavy and light chain isotype of the original CD5+ malignant B cells, and both showed the Same base difffXence resulting in an amino acid replacement (Gln instead of His) when compared with the VH4-2-1 gene, and their sequence was identical to that of the VH4-I8 gene, which could either be the germinal counterpart or a polymorphic variant ofthe 2-1 gene (Fig 2) . In both cases, the Same sequence was obtained from isolated Cloningandsequencing ofthe variable heavy chain region. Polyproximately 1 p g of genomic DNA or single-stranded cDNA by using Taq DNA polymerase (Cetus, Perkin Elmer, Emeryville, CA) according to the manufacturer's protocole. The 5' primers used for VH gene amplification were designed to anneal to the framework 1 sequence of VH 1 to 6 families, and the consensus JH was used as the 3' primer. They were the same as those used by Deane and Norton" and were synthesized in the organic chemistry laboratory at the Pasteur InStitUte. They consisted Of (1) VH 1 : CCTCAGTGA-AGGTCTCCTGCAACG (2) VH2: TCCTGCGCTGGTGAAAG-P B L~ and from the hybrid. Hybrid col, which secreted a polyreactive antibody, was found to use a VH4 family CCACACA; (3) VH3: GGTCCCTGAGACTCTCCTGTGCA~ (4) member whose closest germinal identity was the VH4-2 1 VH4a: TCGGAGACCCTGTCCCTCACCTGCA; VH4b CGCT-GTCTCTGGTTACTCCATCAG; ( 5 ) VH5: GAAAAAGCCCGG-ACAGTG; whereas the consensus JH primer consisted of amplification (95°C for 1 minute, 62°C for 1 minute, and 72°C 1 minute) were performed on isolated genomic DNA or cDNA. In the case of VK genes, the primers used in 5' were as fO~lOWS:
(1) VKI: GACATCCAGATGACCCAGTCTCC; (2) VKII GATATTGTGATGACTCAGTCTCc; (3) VK1ll ACCCTGTCT-CGTGATGACCCAGTTCTC. In 3', the consensus JK primer
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was used. For x light chains, the vxFwl p"mer CAGTCTGTG-CTGACTCAG in 5' and the ch CACACYAGTGTRGCCTGGTT in 3' were used. The amplified fragment was size-selected on a 2% low agarose gel containing 1 pg/mL ethidium bromide and the band was excised, purified, ligated in blunt ends into the Sma I site in a pTZ18R Phagemid vector (Sigma, St Louis, MO), and transformed into XL1-blue or TGl Escherichia coli. Transformed cells were selected in culture medium containing ampicillin. Recombinant plasmids were purified from transformed bacteria and selected by restriction analysis. Nucleotide sequencing was performed by the dideoxy chain termination method using the "Taq Track" kit (Madison, WI). All inserts were sequenced from two directions and from multiple independent clones. Nucleotide sequence data were analyzed and comparisons were performed with the Genetics Computer Group, Inc (Madison, WI) software package and the Genegene (90%). The extensive mutations found for this gene HuC, displaying anti-Sm antibody activity, was found to counterpart was the 30PI gene (95.2%). When compared with its germinal counterpart, it displays 12 base differences resulting in 8 amino acid substitutions (2 in CDR1, 3 in CDR2, I in F W I , and 2 in FW2). Hybrids Aig, Fon, and Por, displaying rheumatoid factor activity, expressed 5 1P1 gene, Aig displayed an identical sequence, whereas Fon was 93.5% identical to it, with an unusual number of nucleotide differences in the framework regions, particularly framework 3 ( 1 amino acid substitution in CDR I , 2 in CDR2, 1 in FW2, and 6 in FW3). This last feature is unusual and raises the possibility that the Fon gene could be the product of a previously unknown VH gene segment, rather than a highly mutated version of 5 1 pi. Hybrid por expressed a VH 1 gene with 98.8% homology With that previously described by Dersimonian et a 1~8 for 2 1 128 and gE 1 0 hybridomas. Hybridoma 2 1 f 28 secreted a 1616 idiotypenegative anti-DNA antibody and was derived from a lupus Patient, whereas 8E10 was derived from a leprosy patient. The two base differences from these genes were located in the same codon in Fw1, resulting in a single amino acid GGAGTCTCTGAA; and (6) 
V GENE USAGE BY CLLS WITH AUTOANTIBODY ACTIVITY

3105
COR1
CWtZ replacement (Gly instead of Phe). The germinal counterpart of this gene is V1-3b, which has recently been de~cribed.'~ Analysis of the D and JH segments. The third hypervariable region (CDR3) results from VH-DH-JH joining and is of major importance in generating antibody specificity and diversity. Junctional flexibility and N segment addition by terminal deoxynucleotidyltransferase creates considerable difficulty in the assignment of DH origin. Clone Aig (Fig 3) was found to use the DLR4 germinal segment. Clones Por, Mar, and Mal used the DN2 segment (Fig 3) . However, assignment of a D segment origin for clones Col, Huc, and Fon remained problematic. It was difficult to ascertain whether these clones expressed D segments corresponding to additional, as yet undescribed D segments.
It has recently been reported that, in human adults, JH4 is the most frequently used segment, followed by JH6 and JH5, whereas in the fetal repertoire there is overexpression of JH3 and JH4.I4 JH use was JH4 for Por and Fon, JH5 for Huc and Col, JH6 for Mar and Aig, and JH3 for Mal.
The complete variable amino acid light chain sequence of the seven hybrids is represented in Fig 1. Col ing 100% homology (Fig 4) with a gene reported in the case of an antibody directed against the HIV gp120 glycoprot e i~~.~' Although the germinal counterpart of this gene has not been reported as yet, the fact that this gene was found to be identical in two unrelated individuals makes it likely that the VK segment encoding them corresponds to a conserved germline gene. Both Por and Fon, which displayed rheumatoid factor activity, used a VKII gene with, respectively, 97.4% and 96.6% homology (8 nucleotide differences predominating in framework regions and resulting in 5 and 4 amino acid replacements, respectively; Fig 4) with a gene previously described in a lymphoblastoid cell line obtained from a patient suffering from acute myeloblastic leukemia.31 Clones Mal and Mar, which exhibited a polyreactive pattern of binding and expressed the VH4-18 gene in germinal configuration, both used X light chains in germinal configuration (Fig 4) . Mar expressed a member of subgroup 111 whose germinal counterpart has been previously reported by Combriato and Kl~beck,~* whereas Mal expressed a germinal member of subgroup VI1 previously found in a recombinant library of chromosome Clone Aig with rheumatoid factor activity used a VXI gene show- regions of the light chains from the 7 hybrids. The germinal counterpart of the JL genes is overlined and the CDRB segment is underlined. 3' primer used for hybrids expressing x is underlined. In the case of hybrids expressing A, the primer used was a cX, which is not represented. Fig 4) with H u~I G L V I I I .~~ For JL expression, Col used JKI, Fon used JKII, and Por used JKIV, whereas Mar and Aig used JX1 segments and Mal and Huc used JX2/3 (Fig 3) . The set of these structural results is summarized in Table 2 .
Analysis of JL segments.
DISCUSSION
Studies on the antibody function of paraproteins and other B-cell malignancies indicate that the autoreactive Bcell repertoire involved in production of NAAB frequently undergoes malignant tran~formation.~~ About 30% ofmonoclonal IgM paraproteins display antibody activity against the Fc portion of IgG,37-39 blood group Ii,40,4' myelin-associated g l y c o p r~t e i n ,~~~~~ or polyreactive binding activity." The latter specificity is also found in at least 10% of monoclonal IgG and IgA." More recently, similar high frequencies of NAAB activity have been found among hybrids derived from CD5-low-grade follicular small-cleaved and follicular mixed-cell lymphomas45 and CD5' CLL B lymphocytes,'@'' indicating that both CD5' and CD5-B cells are probably involved in the production of NAAB.
In terms of gene expression, highly restricted use of the 5 1 P 1 VH and HumKv325 germinal genes has been shown in cryoglobulins expressing the Wa idiotype, which account for 60% of monoclonal cryoglobulin^.^^^^^ The VH4-2 1 gene has been found to be invariably expressed in cold agglutinins with a n t i 4 spe~ificity,~,~' in frequent association with the HumKv325 gene.4' Paraproteins with antibody activity against DNA frequently express the 30P1 VH3 gene.28 In CD5' B-CLL, overexpression of minifamilies VH4,5, and 6 has been consistently observed, although frequencies vary in the different report^.^'-'^ In our hands, VH4 was expressed in 17% of cases, VH5 in 8%, and VH6 in 14%, as compared with an expected complexity of 12%,2%, and 1% for VH4, VH5, and VH6, re~pectively.'~ Kipps et alZ4 reported that 20% of CLL patients rearrange the 5 1P1 VHI gene and that about 25% of CLL expressing K at the membrane use the HumKv-325 VKIII gene,'5 whereas Humphries et aIz0 found a high incidence of the VH5-25 1 gene. However, in most of these studies, the relationship between antibody activity and V gene usage could not be determined.
In the present report, we determined the nucleotide sequence of the heavy and light chain variable segments from seven hybridomas obtained from CLL B lymphocytes, all displaying autoantibody activity. In a previous report, we showed that hybrids studied here were derived from the malignant CD5' B cell, because (1) all hybrids secreted heavy and light chains with the same isotype observed for surface membrane Igs; and (2) all hybrids obtained for a single patient expressed the same heavy and light chains and the same antibody specificity. Moreover, in all seven cases studied here, stimulation with PMA resulted in secretion of the same heavy and light chain isotype observed for hybrids, and secreted Igs displayed the same antibody activity. In the present report, we provide additional evidence for this, because the same sequence was found in PBLs and hybrids for patients Mar, Mal, and Huc. For patients Mar and Mal, in whom the nucleotide sequence was performed in at least 8 different clones, we established the incidence of Taq polymerase infidelity in our system at 1 base for every 250.
Taken together, our results showing that 2 of 3 clones that display rheumatoid factor activity use the VH1-51PI gene are in agreement with previous findings by Kipps et who reported frequent use of this gene in CLL, almost always in a germinal configuration, as was the case for patient Aig. However, B lymphocytes from patient Fon that used this gene displayed 15 base differences predominating in the FW3 region, raising the possibility that Fon might use another previously unknown VH gene segment. Taking into account that the entire human VH database is incomplete and that the full extent of polymorphism among human VH genes is not known, the search for a germinal counterpart in the patient's DNA constitutes the only way to resolve this issue. This was unfortunately impossible for patient Fon, who died in 1990. Nevertheless, the fact that the VKII gene expressed by this patient differs from any known germinal sequence may constitute indirect evidence that the differences observed in the Fon V genes reflect somatic mutations. Patient Por expressed a different VHI gene (V1-3b), which has been described in one case of CLL, and is committed to secreting anti-ssDNA and ~a r d i o l i p i n .~~ Recurrent use of the 30P1 gene was reported for anti-DNA antibodies expressing the 16-6 idiotype.28 In CLL, this gene was previously shown in one case with an anti-myelin/DNA ant i b~d y ,~' and in one particular case of CLL expressing IgA at the membrane.46 We report here the nucleotide sequence of an antism antibody derived from CLL B cells that used a VH gene whose closest homology was the 30Pl germinal gene. To our knowledge, the only antism antibody for which a sequence could be obtained was that reported by Sanz et al,48 which used a different VH3 family member (the 20P1 gene) in a germinal configuration. Taken together, these data indicate that the same gene can encode for different antibody specificities, lending support to recent evidence from Martin et suggesting that the CDR3 segment and/or the associated VL gene play an important role in determining autospecificity. Interestingly, polyreactive clones Mar and Mal expressed the same VH4-18 gene in a germinal configuration. Patient Col, suffering from IgG+CD5+ B-CLL, was found to express the VH4-2 I gene. In a previous report, which included 7 cases of IgG+ CD5+ B-CLL, VH4-18 in a germinal configuration was found in 2 cases, whereas in 3 cases, a VH4 gene with homology varying from 91% to 95% with the germinal VH4-21 was found.50 These results suggest that, in addition to overexpression of the 5 1 PI gene, there may exist a nonstochastic use of VH4 genes, because (including our results) 13 of 17 VH4 sequences reported in CLL were found to use 4-18 (7 cases) and 4-2 1 (6 cases), whereas the developmentally regulated 58P2, known to predominate in fetal repertoires, was shown in only 1 ~a s e .~' *~' -~~ Although early worki3 pointed to stochastic VH gene usage in the adult B-cell repertoire, recent reports stressed biased usage of some genes such as 30P1, 20P1, VH4-2 1, the single VH6 gene, and a member are overrepresented, at least in the initial series.l3 Our results on 7 different clones with autoantibody activity confirm the frequent use of some of these genes. Concerning VL gene usage in CLL, available evidence is scarce. An early report from Kipps et aI2' suggested overexpression of the Humkv325 gene in CLL, whose frequent association with the SIP1 gene is reminiscent of B cells found in the mantle layer of germinal centers. In our study, 3 of the 7 light chains expressed by the hybrids were K , but none of them expressed the Humkv325 gene despite the fact that the three clones exhibited rheumatoid factor activity. Interestingly, Por and Fon expressed the same VKII gene. The four other hybrids expressed different X genes, which were in germinal configuration for 3. It is noteworthy that the four hybrids displaying VH genes in germinal configuration also expressed VL genes in germinal configuration, with the exception of Por. Whether these cases constitute a particular subset among CLLs remains to be defined. In contrast to the virgin state observed for CLLs expressing 51P1 and VH4-18 gene, CLL sequences containing the VH5-25 1 56 and the VH4-2 1 51,54 appear to frequently express these genes in a mutated form, which in some cases might be reminiscent of an antigen-driven pro~ess.'~ As a whole, these results indicate that the autoreactive B-cell repertoire frequently undergoes malignant transformation. It can be hypothesized that activation of this repertoire by continuous challenge by self-antigens or by id-antiid interactions may induce continual cell cycling and create favorable conditions for clonal expansion and malignant transformation. In support of this view is the observation that, in both mice and humans, NAAB precursors are often in a proliferative ~t a t e .~~.~~ However, the binding specificities of antibody molecules are the consequence ofthe assembling of V, D, and J genes for heavy chains and of V and J genes for light chains. This combination of events generates a wide diversity of antigen-binding activities that, in adult lymphoid tissue, appears to be random.13 Interestingly, antibody specificities are developmentally regulated and there is increasing evidence to indicate that the fetal preimmune repertoire uses a limited set of V genes that frequently encode aut~antibodies.''-~' In addition, CLL is a CD5+ B-cell tumor and CD5+ B cells predominate during fetal life6'; indeed, preferential usage of certain V genes could reflect transformation of the progeny of these early lineage B cells. Reports indicating high expression of some of these recurrent V genes in pre-B-cell malignancies that do not express functional surface Ig lend supporting evidence to the hypothesis that overexpression of these genes is not the consequence of an antigen selection Nevertheless, a recent report66 comparing VHl gene expression in pre-B acute lymphoblastic leukemia (ALL) and CLL showed consistent overexpression of 5 1 P 1 in CLL (3 of 9 cases as compared with 0 of 9 in ALL), whereas overrepresentation of 20P3 was found for ALL (5 of 9 as compared with 0 of 9 in CLL). We are now comparing VH4 gene expression in CLL and ALL to gain a better insight into this question.
